Exploració per tema "Multiple sclerosis."
Ara es mostren els items 1-6 de 6
-
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
(2009-10)
Article
Accés restringit per política de l'editorialInflammation and neurodegeneration may have differential impacts on disease evolution in the different forms of multiple sclerosis. However, a beneficial effect of immunomodulatory drugs should not be ruled out in primary ... -
Cervical cord atrophy and long-term disease progression in patients with primary-progressive multiple sclerosis
(2018-02-01)
Article
Accés obert -
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI
(2017-04-01)
Article
Accés obertObjectives To compare the sensitivity of enhancing multiple sclerosis (MS) lesions in gadolinium-enhanced 2D T1-weighted gradient-echo (GRE) and spin-echo (SE) sequences, and to assess the influence of visual conspicuity ... -
FLCSFD - A fuzzy local-based approach for detecting cerebrospinal fluid regions in presence of MS lesions
(2009-04)
Comunicació de congrés
Accés restringit per política de l'editorialMagnetic Resonance Imaging (MRI) is an important paraclinical tool for diagnosing Multiple Sclerosis (MS) and providing several markers of disease activity and evolution. Traditionally, hypointense lesions on ... -
Measures in the first year of therapy predict the response to interferon beta in MS
(2009-07)
Article
Accés restringit per política de l'editorialSeveral criteria for treatment response to interferon beta (IFNβ) have been proposed, although there is no consensus among different investigators. Hence, the aim of this study was to investigate magnetic resonance imaging ... -
Neurophysiological evidence of compensatory brain mechanisms in early-stage multiple sclerosis
(2015-08-31)
Article
Accés obertMultiple sclerosis (MS) is a chronic central nervous system disorder characterized by white matter inflammation, demyelination and neurodegeneration. Although cognitive dysfunction is a common manifestation, it may go ...